BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 32448204)

  • 1. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
    Erber J; Weidlich S; Tschaikowsky T; Rothe K; Schmid RM; Schneider J; Spinner CD
    BMC Infect Dis; 2020 May; 20(1):365. PubMed ID: 32448204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous infection with Mycobacterium fortuitum: an unusual presentation.
    Sarma S; Thakur R
    Indian J Med Microbiol; 2008; 26(4):388-90. PubMed ID: 18974500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculous Mycobacteria: Skin and Soft Tissue Infections.
    Gonzalez-Santiago TM; Drage LA
    Dermatol Clin; 2015 Jul; 33(3):563-77. PubMed ID: 26143432
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients.
    Gao J; Pei Y; Yan X; Shi G; Li T; Gao M; Liu Y; Wang Y; Shu W; Li L; Pang Y
    Int J Infect Dis; 2020 Nov; 100():196-198. PubMed ID: 32890726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.
    Philley JV; Wallace RJ; Benwill JL; Taskar V; Brown-Elliott BA; Thakkar F; Aksamit TR; Griffith DE
    Chest; 2015 Aug; 148(2):499-506. PubMed ID: 25675393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complicated skin and soft tissue infection with Mycobacterium fortuitum following excision of a sebaceous cyst in Taiwan.
    Tsai SC; Chen LH; Liao HH; Chiang CY; Lin WL; Chen SC; Tsao SM; Hung HC; Lee YT
    J Infect Dev Ctries; 2016 Dec; 10(12):1357-1361. PubMed ID: 28036317
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure among Patients with Non-Tuberculous Mycobacterial Infections in Skin, Soft Tissue, and Musculoskeletal System in Southern Taiwan, 2012-2015.
    Hsueh JH; Fang SY; Hsieh YH; Chen LW; Lee SS
    Surg Infect (Larchmt); 2019 Sep; 20(6):492-498. PubMed ID: 31066636
    [No Abstract]   [Full Text] [Related]  

  • 10. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin alone efficiently treated a cutaneous mycobacterium fortuitum infection.
    Fujita N; Utani A; Matsumoto F; Matsushima H; Kakuta M; Hatamochi A; Shinkai H
    J Dermatol; 2002 Jul; 29(7):452-4. PubMed ID: 12184647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].
    Régnier S; Martinez V; Veziris N; Bonvallot T; Meningaud JP; Caumes E
    Ann Dermatol Venereol; 2008; 135(8-9):591-5. PubMed ID: 18789296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
    Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of skin and soft tissue infection caused by non-tuberculous mycobacteria in Taiwan.
    Hsiao CH; Tsai TF; Hsueh PR
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):811-7. PubMed ID: 21575304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of pleural effusion caused by Mycobacterium fortuitum and Mycobacterium mageritense coinfection.
    Hirabayashi R; Nakagawa A; Takegawa H; Tomii K
    BMC Infect Dis; 2019 Aug; 19(1):720. PubMed ID: 31416441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal infection due to Mycobacterium fortuitum.
    Nguyen DQ; Righini C; Darouassi Y; Schmerber S
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Sep; 128(4):197-9. PubMed ID: 21596645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft tissue infection due to Mycobacterium fortuitum following acupuncture: a case report and review of the literature.
    Guevara-Patiño A; Sandoval de Mora M; Farreras A; Rivera-Olivero I; Fermin D; de Waard JH
    J Infect Dev Ctries; 2010 Sep; 4(8):521-5. PubMed ID: 20818105
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.
    Gil E; Sweeney N; Barrett V; Morris-Jones S; Miller RF; Johnston VJ; Brown M
    Emerg Infect Dis; 2021 Mar; 27(3):944-948. PubMed ID: 33622490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.